Dartmouth researchers have found a machine learning method that can predict the likelihood that a high-risk type of breast lesion is cancerous, potentially saving some women from unnecessary surgeries and overtreatment.
Deborah Hogan, PhD, a professor of microbiology and immunology at Dartmouth’s Geisel School of Medicine, has been named a 2019 Fellow of the American Academy of Microbiology based on her record of scientific achievement and original contributions to the field of microbiology.
Global health teams from Geisel and its partner organizations held a symposium in Dar es Salaam in December to provide critical updates in TB care, prevention, and research. The event was the latest step in their 17-year history of working collaboratively to combat HIV-related TB in Tanzania.
Arielle Baker, Guarini ‘19, a PhD candidate in the neuroscience track of the Program in Experimental and Molecular Medicine (PEMM), has received a Christine Mirzayan Science & Technology Policy Graduate Fellowship. She will be working with the Committee on Women at the National Academies of Science, Engineering, and Medicine (NASEM) to advocate for the participation and retention of women in these disciplines.
Steven D. Leach, MD, director of the Dartmouth-Hitchcock Norris Cotton Cancer Center and the Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer at the Geisel School of Medicine at Dartmouth, has been named a Fellow of the American Association for the Advancement of Science.
Results from an innovative new study conducted by a team of researchers at Geisel are the first to show that machine learning approaches can be used to identify potential substance use risk behavior, such as alcohol use, among social media users.
Geisel professor and surgeon Richard Barth, MD, teamed up with two Thayer engineers to dramatically improve the accuracy of breast cancer surgery.
Every year, hundreds of Dartmouth undergraduates learn the ins and outs of research with Geisel faculty.
Dedicated to mentoring Geisel students interested in research, Paul Barr, PhD, values their perspective and views them as a natural conduit between the medical and research communities.
Results from a new study led by researchers at Geisel and presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, showed that stem cell transplantation was beneficial to scleroderma patients who don’t respond to current immunosuppressive therapies.